Given the impact of postoperative Clostridium difficile infection, a heightened sense of suspicion should be given to symptomatic patients after stoma reversal.
It is important to understand the relative severity of CDI in patients in the ICU because it effects treatment decisions. However, primary prevention remains a vitally important strategy to limit morbidity and mortality related to CDI in this vulnerable patient population.
The agency took this action after Triangle Pharmanaturals LLC failed to cooperate with the FDA's request to conduct a voluntary recall.
There were declines in mortality from most categories of infectious diseases, with large differences among US counties. However, over this time there was an increase in mortality for diarrheal diseases.
FIRVANQ is commercially available in 25 and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes.
Helicobacter pylori treatment is associated with a reduced rate of metachronous gastric cancer.
Recurrent Salmonella enterica Typhimurium infection disables host protection against intestinal inflammation [PreClinical]February 04, 2018
Increased turnover of intestinal alkaline phosphatase (IAP), related to increased endogenous neuraminidase activity among duodenal enterocytes, was found to be associated with inflammatory bowel disease.
Vancomycin is the first liquid oral treatment for C diff-associated diarrhea.
Study aimed to clarify the prevalence of gallbladder diseases, and factors related to gallbladder diseases, and relationships between H pylori infection, gallstones, cholecystitis, and cholecystic polypus.
Study found that many hospitalized infants did not receive rotavirus vaccination before discharge and were no longer age-eligible for vaccination after discharge from the hospital.
Raw flour has been linked to E coli infections in 24 states.
The Infectious Diseases Society of America updated its guidelines for the management of acute or persistent infectious diarrhea.
Refractory Helicobacter pylori infection can be successfully treated with goshuyuto and rabeprazole.
In recent years, a link between childhood Helicobacter pylori and gastric cancer in adulthood has elevated the need to detect and treat H pylori in asymptomatic children.
Bezlotoxumab, given with antibacterials for Clostridium difficile, could be effective as a preventive treatment for C difficile infection.
Implementation of rotavirus vaccination correlated with a reduction in acute gastroenteritis related hospitalization rates among children.
The CDC Health Alert Network has issued an advisory regarding an increase in cases of the intestinal illness cyclosporiasis.
Experts review biotherapeutics for the prevention of C difficile infection, including probiotics, fecal microbiota transplantation, and nontoxigenic C difficile.
The addition of bismuth subcitrate to levofloxacin-based triple therapy is not associated with increased effectiveness in patients with Helicobacter pylori infection.
The rate of multiply recurrent Clostridium difficile (mrCDI) was found to be more than 4 times higher than that of original CDI, with important implications for treatment decisions.
Results of a recent study have shown that infection with Clostridium difficile is increasing in frequency and negatively affects clinical and care outcomes in patients with cancer.
Therapeutic donor microbes can remain for months or years in patients who've undergone fecal microbiota transplantation.
Liver cancer has become the fastest growing cause of cancer deaths in the Unites States.
Experts review novel antibiotic therapies that may limit the impact on the gut microbiome, as well as passive immunization products that may bolster the immune response to C difficile toxins and possibly reduce the frequency of toxigenic strains.
A patient who recently acquired a new tattoo developed Vibrio vulnificus septic shock after swimming in seawater, leading to death.
Recurrent Clostridium difficile infection is associated with a significant economic and mortality burden, but new treatment shows promise.
The FDA granted Breakthrough Therapy designation to Synthetic Biologics' ribaxamase SYN-004 for Clostridium difficile infection prevention.
Findings indicate that dysbiotic features that are uniquely ME/CFS-associated may be masked by disturbances arising from the high prevalence of IBS co-morbidity in ME/CFS.
Community-associated C difficile infection in children was linked to the combination of commonly used antibiotics and exposure to the bacterium in the home and outpatient healthcare settings.
The CDC has issued an alert regarding new recommendations for the treatment of Shigella infection.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- An Effective Zika Vaccine May Eliminate Prenatal Infections
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Possible Inhibitory Effect of HCV-Induced Steatogenesis by HBV
- Delayed Management of Severe Sepsis, Septic Shock Increases Mortality
- MenB Vaccine Gets Breakthrough Therapy Designation for Children Ages 1-9 Years
- CDC: Recommendations on the Use of Heplisav-B Published
- Non-Targeted HIV Testing in ED Acceptable to Patients